NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 264 filers reported holding NOVOCURE LTD in Q2 2020. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $278,000 | +5.7% | 4,149 | +31.9% | 0.06% | +5.0% |
| Q1 2022 | $263,000 | -67.2% | 3,146 | -70.6% | 0.06% | -57.4% |
| Q4 2021 | $802,000 | +202.6% | 10,694 | +345.4% | 0.14% | +88.0% |
| Q3 2021 | $265,000 | -76.8% | 2,401 | -72.0% | 0.08% | -67.1% |
| Q1 2021 | $1,143,000 | +83.8% | 8,575 | +84.4% | 0.23% | -3.8% |
| Q3 2020 | $622,000 | +6.9% | 4,650 | -54.0% | 0.24% | +62.3% |
| Q2 2020 | $582,000 | -2.3% | 10,100 | +34.4% | 0.15% | -7.6% |
| Q4 2019 | $596,000 | – | 7,517 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |